Revenue

Beyond dashboards: Chord secures $7M to expand its AI that actively runs e-commerce, backed by the founders of Glossier and major brands like Mr. Beast.

Student entrepreneurs from 15 countries converge in San Diego to pitch world-changing ideas, from pineapple-fiber hair ties to crypto for Gen Z.

With patient enrollment accelerating for its novel lung fibrosis drug, LTI-03, Rein Therapeutics signals progress in a field desperate for new options.

Alibaba's Accio Work deploys AI "business teams" to SMEs, managing e-commerce and even launching physical products from scratch for a new era of business.

Seattle startup CounterX Therapeutics to present its novel overdose prevention drug at a top investor event, signaling new hope in the fentanyl crisis.

A modest 0.4% Q1 gain for Canadian pensions masks a dramatic story of geopolitical shocks, a booming energy sector, and a deep tech selloff.

A new national ranking moves beyond funding and publications to reveal which U.S. research institutions are truly effective at creating real-world cures.

A new advisory firm is tackling the opaque world of aesthetic device sales, promising to save providers up to $80,000 on high-ticket equipment.

Once a hospital disinfectant, hypochlorous acid is now a skincare star. Magic Molecule's massive CVS launch signals a major shift in the beauty industry.

As cargo capacity shrinks and tensions rise, FedEx leverages new routes and digital tools to keep critical medical supplies moving across the Middle East.

Italian biopharma giant Chiesi makes its largest acquisition ever, targeting KalVista's groundbreaking oral HAE drug to reshape patient care and its future.

A new partnership will allow consumers to spend stablecoins and Bitcoin at 175M+ locations, blurring the lines between digital wallets and everyday commerce.

Snap CEO Evan Spiegel will headline Augmented World Expo, unveiling new tools from subsidiary Specs Inc. and charting a course for human-empowered spatial AI.

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

A startling report shows most banks struggle to measure marketing ROI, citing outdated tech and compliance hurdles. Is specialized affiliate marketing the answer?

With a new industry giant on its board and fresh funding, Phagenesis is set to scale its groundbreaking neuromodulation therapy for swallowing disorders.

NBA star Russell Westbrook's new ad tech platform aims to revolutionize marketing by putting authentic cultural intelligence at the core of its strategy.

With huge energy needs, Israel's water company Mekorot turns to nT-Tao's fusion tech in a bold move that could redefine national infrastructure resilience.

A new report shows most procurement and IT teams collaborate, but a failure on AI governance is stalling deployment and creating enterprise-wide risk.

As AI and usage-based pricing complicate finance, BillingPlatform launches RevVenue, an expert-led hub to help firms navigate a new era of compliance risk.